Shaedon Sharpe
#17SG · Portland Trail Blazers
Fan Verdict
Grade this player:
Career StatsB
| Year | GP | PPG | RPG | APG | SPG | BPG | FG% | 3PT% | FT% |
|---|---|---|---|---|---|---|---|---|---|
| Career | 232 | 15.8 | 4.0 | 2.2 | 0.8 | 0.3 | 45.1% | 33.3% | 78.0% |
| 2025-26 | 48 | 21.4 | 4.4 | 2.6 | 1.4 | 0.1 | 45.6% | 34.0% | 78.4% |
| 2024-25 | 72 | 18.5 | 4.5 | 2.8 | 0.9 | 0.2 | 45.2% | 31.1% | 78.5% |
| 2023-24 | 32 | 15.9 | 5.0 | 2.9 | 0.9 | 0.4 | 40.6% | 33.3% | 82.4% |
Current Contract
Length
5 years
Total Value
$28.5M
AAV
$5.7M/yr
Contract Value Index (CVI)
Shaedon Sharpe's contract with the Portland Trail Blazers grades out as a good value contract, earning a B CVI grade. At $5.7M per year over 5 years, this is a role player contract. Shaedon's deal falls in the role player tier for NBA Shooting Guards. At 22 years old, Shaedon is in or near prime years, which supports the investment. The front office found good value in the open market with this signing. This contract should provide positive value over its duration if performance holds steady.
Performance Analysis
Shaedon Sharpe earns a B Performance grade, reflecting above-average production for a Shooting Guard. Across 232 career games, Shaedon has averaged 15.8 points, 4.0 rebounds, and 2.2 assists per game. Shaedon's strongest metric is FG% at 4507.1, compared to the NBA Shooting Guard median of 46.0. The biggest area for improvement is APG at 2.2, below the Shooting Guard median of 4.0. Among 147 NBA Shooting Guards graded this season, Shaedon ranks 12th in overall performance. Shaedon is a quality starter contributing on both ends for the Portland Trail Blazers.
Current Sentiment
Media views Sharpe as talented but injury-prone, creating cautious optimism mixed with concern. His B-grade performance shows promise, though injuries repeatedly derail momentum and consistency. The $90M extension seems premature given durability questions and unproven All-Star trajectory. Injury plaguing his development is the dominant narrative overshadowing any positive narratives. Fans remain hopeful but increasingly skeptical about whether Sharpe stays healthy enough to justify investment.
Transaction History
No transactions found for this player.